---
layout: post
title: "New project to develop a drug to fight cognitive impairment associated with schizophrenia"
date: 2015-12-07
categories: Technology
author: unknown author
tags: [Pharmaceutical drug, Neuropsychopharmacology, Mental disorder, Centre for Genomic Regulation, Health, Research, Disease, Schizophrenia, Model organism, Biotechnology, Medicine, Biology, Health sciences, Life sciences, Clinical medicine, Health care]
---




#### Extract
>(Center for Genomic Regulation) The goal of 'Spark' is to carry out the first preclinical stage of the development of a first-in-class drug that will prevent, stop and reverse the progression of cognitive impairment associated with schizophrenia and other mental disorders, and to be able to start first-in-humans trials by 2016....



[Visit Link](http://www.eurekalert.org/pub_releases/2015-01/cfgr-npt012715.php)


